- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03207516
Sourdough Bakery Products and Digestive Function (Digeribilità)
June 30, 2017 updated by: EMANUELE NICOLAI, Irccs Sdn
Impact of Bakery Products With Sourdough or Brewer's Yeast on Digestive Function: a Double Blind Randomised Study in Healthy Subjects
In a double-blind, randomised crossover study, two sourdough croissants (SC) or two brewer's yeast croissants (BC) were served to 17 (9 F; Age range 18-40; BMI range 18-24 kg/m2) healthy subjects to evaluate the effects of their ingestion on postprandial gastrointestinal functions.
Hydrogen breath test was performed to measure H2 production after SC and BC ingestion.
Gastric volume was evaluated by Magnetic Resonance(MR) Imaging to calculate gastric emptying rate in the 3-hour interval following croissant ingestion.
Palatability and postprandial gastrointestinal symptoms and perceptions over a 4-h period after the meal were evaluated by visual analogue scale (VAS).
In addition, in the 3-hour interval, blood samples were drawn to measure serum glucose levels.
The area under the curve (AUC) was employed to evaluate global kinetics of all parameters and the T-test was used to evaluate differences between groups.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In this monocentric study, a double-blind, randomised crossover design was used, with washout periods of at least one week between study days.
A standardized meal consisting of two 100 g croissants prepared with sourdough or with brewer's yeast was administered randomly to 17 (9 F; Age range 18-40; BMI range 18-24 kg/m2) healthy subjects after an overnight fast (at least 8 h) and consumed in a 10-minute interval with 300 mL of water.
Immediately after meal ingestion, subjects were asked to evaluate croissant palatability.
Gastric volume was evaluated by Magnetic Resonance(MR) Imaging to calculate gastric emptying rate in the 3-hour interval following croissant ingestion.
Hydrogen breath test was performed to assess gastrointestinal fermentation measuring H2 production after SC and BC ingestion.
Postprandial gastrointestinal symptoms and perceptions over a 4-h period after the meal were evaluated by visual analogue scale (VAS).
In addition, in the 3-hour interval, blood samples were drawn to measure serum glucose levels.
The protocol was repeated twice in each subject, once with sourdough croissants (SC) and once with brewer's yeast croissants (BC), dispensed according to a computer generated randomisation list created by RC following simple randomisation procedures (computerized random numbers).
The area under the curve (AUC) was employed to evaluate global kinetics of all parameters and the T-test was used to evaluate differences between groups.
Study Type
Interventional
Enrollment (Actual)
17
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion criteria:
- age ranging between 18 and 40 yrs
- normal-weight (body mass index 18-24.9 kg/m2),
Exclusion criteria:
- smoke
- functional or organic gastrointestinal disease
- gluten allergy
- dyslipidemia
- diabetes
- psychiatric disorders
- claustrophobia
- pregnancy
- breast-feeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Sourdough --> Brewer's Yeast
Sourdough --> Brewer's Yeast
|
Impact of bakery products with sourdough or brewer's yeast on digestive function
Impact of bakery products with sourdough or brewer's yeast on digestive function
|
Active Comparator: Brewer's Yeast --> Sourdough
Brewer's Yeast --> Sourdough
|
Impact of bakery products with sourdough or brewer's yeast on digestive function
Impact of bakery products with sourdough or brewer's yeast on digestive function
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of gastric emptying
Time Frame: 0, 3, 6, 9, 12, 15, 20, 25, 30, 45, 60, 75, 90, 120, 150, 180 minutes after the ingestion of the test meal
|
Gastric volume in mL was evaluated by Magnetic Resonance(MR) Imaging using a 3-Tesla MR scanner (Biograph mMR, Siemens Healthcare, Erlangen, Germany) to calculate gastric emptying rate in the 3-hour interval following croissant ingestion
|
0, 3, 6, 9, 12, 15, 20, 25, 30, 45, 60, 75, 90, 120, 150, 180 minutes after the ingestion of the test meal
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of gastrointestinal fermentation
Time Frame: The hydrogen concentration in end expiratory air (expressed in ppm) was determined before consuming the test meal and then at 45, 60, 90, 120, 150, 180 and 240 minutes following meal ingestion.
|
Hydrogen breath test (Gastrolyzer+TMMedimar) was performed to measure H2 production expressed in ppm after SC and BC ingestion
|
The hydrogen concentration in end expiratory air (expressed in ppm) was determined before consuming the test meal and then at 45, 60, 90, 120, 150, 180 and 240 minutes following meal ingestion.
|
Palatability
Time Frame: Croissant palatability was evaluated immediately after meal ingestion
|
Palatability were evaluated by visual analogue scale (VAS, expressed in mm)
|
Croissant palatability was evaluated immediately after meal ingestion
|
Change of gastrointestinal symptoms
Time Frame: The presence and severity of gastrointestinal symptoms were assessed before test meal ingestion and at 45, 60, 90, 120, 150, 180 and 240 minutes after ingestion.
|
postprandial gastrointestinal symptoms (gastrointestinal discomfort, bloating, nausea, fullness) were evaluated by visual analogue scale (VAS, expressed in mm) over a 4-h period after the meal
|
The presence and severity of gastrointestinal symptoms were assessed before test meal ingestion and at 45, 60, 90, 120, 150, 180 and 240 minutes after ingestion.
|
Change of gastrointestinal perceptions
Time Frame: The presence and severity of gastrointestinal perceptions were assessed before test meal ingestion and at 45, 60, 90, 120, 150, 180 and 240 minutes after ingestion.
|
postprandial gastrointestinal perceptions (hunger, appetite, satiety and gastrointestinal wellbeing) were evaluated by visual analogue scale (VAS, expressed in mm) over a 4-h period after the meal
|
The presence and severity of gastrointestinal perceptions were assessed before test meal ingestion and at 45, 60, 90, 120, 150, 180 and 240 minutes after ingestion.
|
Glycemic profile
Time Frame: Blood samples were collected before test meal ingestion and at 15, 45, 60, 90, 120 and 180 minutes after the meal.
|
blood samples were drawn to measure serum glucose levels in mg/dL
|
Blood samples were collected before test meal ingestion and at 15, 45, 60, 90, 120 and 180 minutes after the meal.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Emanuele Nicolai, Irccs Sdn
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 22, 2014
Primary Completion (Actual)
April 28, 2015
Study Completion (Actual)
April 28, 2015
Study Registration Dates
First Submitted
June 23, 2017
First Submitted That Met QC Criteria
June 30, 2017
First Posted (Actual)
July 2, 2017
Study Record Updates
Last Update Posted (Actual)
July 2, 2017
Last Update Submitted That Met QC Criteria
June 30, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1-14_Digeribilità
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dyspepsia
-
King Chulalongkorn Memorial HospitalRecruiting
-
Wuhan Central HospitalNot yet recruiting
-
Dong-A ST Co., Ltd.Not yet recruitingFunctional DyspepsiaKorea, Republic of
-
Universitaire Ziekenhuizen KU LeuvenRecruiting
-
Universitaire Ziekenhuizen KU LeuvenRecruiting
-
Zeria PharmaceuticalRecruitingFunctional DyspepsiaJapan
-
Hong Kong Baptist UniversityXiyuan Hospital of China Academy of Chinese Medical SciencesRecruitingFunctional DyspepsiaHong Kong
-
Seoul National University HospitalCompletedFunctional DyspepsiaKorea, Republic of
-
Wonju Severance Christian HospitalCompletedFunctional DyspepsiaKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.CompletedFunctional DyspepsiaKorea, Republic of
Clinical Trials on Sourdough --> Brewer's Yeast
-
University of ParmaCompletedDietary ModificationItaly
-
Oy Karl Fazer AbCompletedIrritable Bowel Syndrome | Wheat SensitivityFinland
-
KU LeuvenRecruitingGastric Emptying | Energy Intake | Satiety | Appetite | Glucose Response | Insulin ResponseBelgium
-
TNONederlands Bakkerij Centrum; PepsiCo, Inc.Completed
-
KU LeuvenRecruitingAppetite Regulation | Energy IntakeBelgium
-
University of FloridaLallemand Bio-IngredientsActive, not recruiting
-
Tel-Aviv Sourasky Medical CenterWeizmann Institute of ScienceCompletedBody Weight Changes | Dietary Modification | Gastrointestinal Microbiome | Bread | Hematologic TestsIsrael
-
Huazhong University of Science and TechnologyUnknown
-
Shanghai Zhongshan HospitalShanghai Changzheng HospitalRecruitingChronic Lymphocytic Leukemia Stage A(0) | Chronic Lymphocytic Leukemia Stage A(I) | Chronic Lymphocytic Leukemia Stage A(II) | Chronic Lymphocytic Leukaemia Stage B(I)China
-
Xiaofan XuActive, not recruitingAlzheimer Disease | Mild Cognitive ImpairmentChina